A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod
Background: Although the aggregate of data among patients with multiple sclerosis (MS) have shown similar efficacy between dimethyl fumarate (DMF) and fingolimod (FTY), most studies have not assessed long-term worsening of disability. We compared long-term disability worsening over 5 years, as asses...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2021-06-01
|
| シリーズ: | Therapeutic Advances in Neurological Disorders |
| オンライン･アクセス: | https://doi.org/10.1177/17562864211021177 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|